Clinical Trials List
2024-02-01 - 2028-12-31
Phase III
Recruiting10
ICD-10I10
Essential (primary) hypertension
ICD-9401.0
Malignant essential hypertension
-
-
Trial Applicant
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/13
Investigators and Locations
Co-Principal Investigator
- 蔣俊彥 無
- 周銘霆 無
- Zhih-Cherng Chen 無
- 施志遠 無
- Chia-Te Liao 無
- 李威杰 無
- 張瑋婷 無
- 林志憲 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 卓士傑 無
- Wei-Chung Tsai 無
- Chun-Yuan Chu 無
- Po-Chao Hsu 無
- Mei Yueh Lee 無
- 吳韋璁 無
- 黃天祈 無
- Yi wen chiu 無
- Ye-Hsu Lu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳志維 無
- 鄭宇倫 無
- Chien-Yi Hsu 無
- Hsi-Hsien Chen 無
- Yung-Ta Kao 無
- Tsung-Lin Yang 無
- 陳彥舟 無
- 蕭卜源 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wen-Chung Yu 無
- 張俊欽 無
- 黃偉銘 無
- Hao-min Cheng 無
- Kang-Ling Wang 無
- 曾致學 無
- Tze-Fan Chao 無
- Chern-En Chiang 無
- 李慶威 無
- 黃少嵩 無
- 蔡依霖 無
- 吳承學 無
- 郭泠 無
- 廖若男 無
- Tse-Min Lu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
45 participants
-
Global
2500 participants
